SCR-LIP-000646 · Claim · machine-readable JSON →
Genome-wide studies suggest common genetic variants may contribute modestly to lipedema susceptibility.
General proposition consolidated from 4 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 5 source(s) · by Amato
- Answers
- 2 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (5)
- Genome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors — Klimentidis et al. (2023) ✓ verified — consistent · cross sectional · 2023 · reading confidence: high
GWAS of an inferred lipedema phenotype in UK Biobank women: 18 genome-wide significant loci (RSPO3, GRB14-COBLL1, VEGFA, ADAMTS9), SNP heritability about 5.13%, correlations with leptin and age at menopause.
This genome-wide association study identifies heritable genetic risk loci for a lipedema phenotype, directly supporting a hereditary influence; genetic correlations with leptin and age at menopause also touch on hormonal/endocrine links. Co - Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort — Grigoriadis et al. (2022) ✓ verified — consistent · cohort · 2022 · reading confidence: high
“Início frequentemente associado a mudanças hormonais (puberdade, gestação, menopausa)”
In a rigorously defined cohort (n=130), onset often followed hormonal changes; first dedicated GWAS found a suggestive locus upstream of LHFPL6 (OR 2.01, P 4x10^-6), replicated independently.
The lipedema article directly reports hormonal triggers of onset and a heritable genetic association (GWAS locus near LHFPL6 with independent replication), supporting both hormonal and hereditary influence, though the genetic signal was onl - Investigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort — Grigoriadis et al. (2021) ✓ verified — contextual · cross sectional · 2021 · reading confidence: high
“Top SNPs included loci associated with lipoma formation, biosynthesis of hormones and lipid hydroxylation.”
Preprint of the same cohort GWAS: only suggestive loci, top SNPs near lipoma formation, hormone biosynthesis and lipid hydroxylation genes.
The GWAS found only suggestive (not genome-wide significant) loci involving hormone biosynthesis and lipid pathways, plus noted frequent family history, consistent with hereditary and hormonal influences; findings require replication, lower - Unraveling lipedema: comprehensive insights and the path to future discoveries — Faria et al. (2025) ✓ verified — contextual · review · 2025 · reading confidence: high
“Genética poligênica: história familiar em 30-89% dos casos; GWAS de 2022 com 130 portadoras identificou 6 regiões (CPE, ZNF25, ZNF33A — biologia do estrogênio)”
Review re-reporting the dedicated lipedema GWAS (CPE, ZNF25, ZNF33A, linked to estrogen biology) and VEGFA, GRB14-COBLL1 loci; family history in 30-89% of cases.
The review directly synthesizes genetic (familial history, GWAS, AKR1C1) and hormonal (puberty/pregnancy/menopause onset, estradiol effects on ASCs) evidence bearing on the onset of lipedema, supporting the affirmative direction; confidence [grade capped moderate->very_low per curated Oxford N6] - Amato ACM, 2020 unverified — contextual · expert opinion · 2020 · risk of bias: high
Expert opinion (no quote available) describes lipedema as multifactorial on a polygenic predisposition.
Context (PECO)
Answers these questions
- Do hormones and heredity influence the onset of lipedema? consistent
- Is lipedema onset influenced by heredity and family history? consistent
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000012